查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881486

外泌體療法市場－全球產業規模、佔有率、趨勢、機會和預測，按外泌體類型、來源、療法、應用、最終用戶、地區和競爭格局分類，2020-2030年預測

Exosome Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Exosome Type, By Source, By Therapy, By Application, By End User, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球外泌體療法市場規模為3,263萬美元，預計2030年將以41.56%的複合年成長率成長至2.6258億美元。外泌體療法利用天然存在的細胞來源奈米囊泡，促進細胞間通訊並將生物活性分子遞送至目標細胞，為多種疾病的治療開闢了新的途徑。市場擴張的根本動力在於人們對胞外體生物學認知的不斷加深、慢性病和老年相關疾病日益普遍（需要更先進的治療方法）以及對生物技術研發的大量投資。

市場概覽
預測期 2026-2030
2024年市場規模 3263萬美元
2030年市場規模 2.6258億美元
2025-2030年複合年成長率 41.56%
成長最快的細分市場 天然外泌體
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：顧客之聲

第5章：全球外泌體療法市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依外泌體類型（天然型、混合型）
    • 依來源分類（間質幹細胞、血液、體液、其他）
    • 依治療方法（免疫療法、化學療法、基因療法）
    • 依應用領域（代謝性疾病、腫瘤、心臟疾病、神經病學、其他）
    • 按最終用戶（醫院和診所、學術和研究機構、其他）
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美外泌體療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲外泌體療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區外泌體療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲外泌體療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲外泌體療法市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球外泌體療法市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Aethlon Medical, Inc.
  • AEGLE Therapeutics Corporation
  • Anjarium Biosciences AG
  • Exogenus Therapeutics SA
  • Lonza Group AG
  • Capricor Therapeutics Inc
  • Avalon GloboCare Corp.
  • Stem Cell Medicine Ltd.
  • Evox Therapeutics Limited.
  • EV Therapeutics

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21063

The Global Exosome Therapeutics Market, valued at USD 32.63 Million in 2024, is projected to experience a CAGR of 41.56% to reach USD 262.58 Million by 2030. Exosome therapeutics involve the utilization of naturally occurring, cell-derived nanovesicles that facilitate intercellular communication and deliver bioactive molecules to target cells, presenting novel therapeutic avenues for various diseases. The market's expansion is fundamentally supported by an escalating understanding of exosome biology, the increasing prevalence of chronic and age-related conditions necessitating advanced treatment modalities, and substantial investment in biotechnology research and development

Market Overview
Forecast Period2026-2030
Market Size 2024USD 32.63 Million
Market Size 2030USD 262.58 Million
CAGR 2025-203041.56%
Fastest Growing SegmentNatural Exosomes
Largest MarketNorth America

Key Market Drivers

The increasing incidence of chronic diseases, particularly cancer, serves as a significant driver for the global exosome therapeutics market. Exosomes offer novel therapeutic avenues through their natural ability to facilitate targeted drug delivery and enable minimally invasive diagnostics, addressing limitations of current treatments. This escalating disease burden necessitates innovative solutions that exosomes are uniquely positioned to provide, aiming for improved efficacy and reduced systemic toxicity. According to the International Agency for Research on Cancer, in 2022, there were close to 20 million new cases of cancer worldwide, highlighting the pressing need for advanced therapeutic strategies and emphasizing the expansive patient population that exosome-based therapies could potentially benefit.

Key Market Challenges

The complexity and cost associated with the large-scale manufacturing and purification of clinical-grade exosomes represent a significant impediment to the expansion of the global exosome therapeutics market. Achieving the necessary purity and quantity of exosomes for clinical applications demands sophisticated and resource-intensive processes, which drives up production expenses. This directly hampers the market by delaying the progression of promising therapies from research and development into commercialization. The intricate nature of isolating and purifying exosomes to meet stringent regulatory standards often results in lower yields and higher per-dose costs, making advanced exosome-based treatments less accessible and financially viable for wider adoption.

Key Market Trends

This involves actively modifying exosomes to enhance their intrinsic capabilities for precise drug delivery and increased therapeutic efficacy, moving beyond their natural properties. Companies are increasingly focusing on engineering exosomes to carry specific payloads directly to disease sites, thereby improving treatment outcomes and minimizing off-target effects. For example, Minovacca, a startup incorporated in January 2025, commercializes universal milk exosomes by chemically and genetically engineering them for target-specific delivery of therapeutics, highlighting this directed approach. This scientific progression is underpinned by extensive collaborative efforts; according to the International Society for Extracellular Vesicles (ISEV), its MISEV2023 guidelines, published in December 2023, incorporated feedback from over 1000 researchers worldwide to standardize and advance exosome research methods, a foundational step for effective exosome engineering.

Key Market Players

  • Aethlon Medical, Inc.
  • AEGLE Therapeutics Corporation
  • Anjarium Biosciences AG
  • Exogenus Therapeutics SA
  • Lonza Group AG
  • Capricor Therapeutics Inc
  • Avalon GloboCare Corp.
  • Stem Cell Medicine Ltd.
  • Evox Therapeutics Limited.
  • EV Therapeutics

Report Scope:

In this report, the Global Exosome Therapeutics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Exosome Therapeutics Market, By Exosome Type:

  • Natural
  • Hybrid

Exosome Therapeutics Market, By Source:

  • Mesenchymal Stem Cells
  • Blood
  • Body Fluids
  • Others

Exosome Therapeutics Market, By Therapy:

  • Immunotherapy
  • Chemotherapy
  • Gene Therapy

Exosome Therapeutics Market, By Application:

  • Metabolic Disorders
  • Oncology
  • Cardiac Disorders
  • Neurology
  • Others

Exosome Therapeutics Market, By End User:

  • Hospitals & Clinics
  • Academic & Research Institutions
  • Others

Exosome Therapeutics Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Exosome Therapeutics Market.

Available Customizations:

Global Exosome Therapeutics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Exosome Therapeutics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Exosome Type (Natural, Hybrid)
    • 5.2.2. By Source (Mesenchymal Stem Cells, Blood, Body Fluids, Others)
    • 5.2.3. By Therapy (Immunotherapy, Chemotherapy, Gene Therapy)
    • 5.2.4. By Application (Metabolic Disorders, Oncology, Cardiac Disorders, Neurology, Others)
    • 5.2.5. By End User (Hospitals & Clinics, Academic & Research Institutions, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2024)
  • 5.3. Market Map

6. North America Exosome Therapeutics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Exosome Type
    • 6.2.2. By Source
    • 6.2.3. By Therapy
    • 6.2.4. By Application
    • 6.2.5. By End User
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Exosome Therapeutics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Exosome Type
        • 6.3.1.2.2. By Source
        • 6.3.1.2.3. By Therapy
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By End User
    • 6.3.2. Canada Exosome Therapeutics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Exosome Type
        • 6.3.2.2.2. By Source
        • 6.3.2.2.3. By Therapy
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By End User
    • 6.3.3. Mexico Exosome Therapeutics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Exosome Type
        • 6.3.3.2.2. By Source
        • 6.3.3.2.3. By Therapy
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By End User

7. Europe Exosome Therapeutics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Exosome Type
    • 7.2.2. By Source
    • 7.2.3. By Therapy
    • 7.2.4. By Application
    • 7.2.5. By End User
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Exosome Therapeutics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Exosome Type
        • 7.3.1.2.2. By Source
        • 7.3.1.2.3. By Therapy
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By End User
    • 7.3.2. France Exosome Therapeutics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Exosome Type
        • 7.3.2.2.2. By Source
        • 7.3.2.2.3. By Therapy
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By End User
    • 7.3.3. United Kingdom Exosome Therapeutics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Exosome Type
        • 7.3.3.2.2. By Source
        • 7.3.3.2.3. By Therapy
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By End User
    • 7.3.4. Italy Exosome Therapeutics Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Exosome Type
        • 7.3.4.2.2. By Source
        • 7.3.4.2.3. By Therapy
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By End User
    • 7.3.5. Spain Exosome Therapeutics Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Exosome Type
        • 7.3.5.2.2. By Source
        • 7.3.5.2.3. By Therapy
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By End User

8. Asia Pacific Exosome Therapeutics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Exosome Type
    • 8.2.2. By Source
    • 8.2.3. By Therapy
    • 8.2.4. By Application
    • 8.2.5. By End User
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Exosome Therapeutics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Exosome Type
        • 8.3.1.2.2. By Source
        • 8.3.1.2.3. By Therapy
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By End User
    • 8.3.2. India Exosome Therapeutics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Exosome Type
        • 8.3.2.2.2. By Source
        • 8.3.2.2.3. By Therapy
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By End User
    • 8.3.3. Japan Exosome Therapeutics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Exosome Type
        • 8.3.3.2.2. By Source
        • 8.3.3.2.3. By Therapy
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By End User
    • 8.3.4. South Korea Exosome Therapeutics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Exosome Type
        • 8.3.4.2.2. By Source
        • 8.3.4.2.3. By Therapy
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By End User
    • 8.3.5. Australia Exosome Therapeutics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Exosome Type
        • 8.3.5.2.2. By Source
        • 8.3.5.2.3. By Therapy
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By End User

9. Middle East & Africa Exosome Therapeutics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Exosome Type
    • 9.2.2. By Source
    • 9.2.3. By Therapy
    • 9.2.4. By Application
    • 9.2.5. By End User
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Exosome Therapeutics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Exosome Type
        • 9.3.1.2.2. By Source
        • 9.3.1.2.3. By Therapy
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By End User
    • 9.3.2. UAE Exosome Therapeutics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Exosome Type
        • 9.3.2.2.2. By Source
        • 9.3.2.2.3. By Therapy
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By End User
    • 9.3.3. South Africa Exosome Therapeutics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Exosome Type
        • 9.3.3.2.2. By Source
        • 9.3.3.2.3. By Therapy
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By End User

10. South America Exosome Therapeutics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Exosome Type
    • 10.2.2. By Source
    • 10.2.3. By Therapy
    • 10.2.4. By Application
    • 10.2.5. By End User
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Exosome Therapeutics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Exosome Type
        • 10.3.1.2.2. By Source
        • 10.3.1.2.3. By Therapy
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By End User
    • 10.3.2. Colombia Exosome Therapeutics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Exosome Type
        • 10.3.2.2.2. By Source
        • 10.3.2.2.3. By Therapy
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By End User
    • 10.3.3. Argentina Exosome Therapeutics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Exosome Type
        • 10.3.3.2.2. By Source
        • 10.3.3.2.3. By Therapy
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Exosome Therapeutics Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Aethlon Medical, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. AEGLE Therapeutics Corporation
  • 15.3. Anjarium Biosciences AG
  • 15.4. Exogenus Therapeutics SA
  • 15.5. Lonza Group AG
  • 15.6. Capricor Therapeutics Inc
  • 15.7. Avalon GloboCare Corp.
  • 15.8. Stem Cell Medicine Ltd.
  • 15.9. Evox Therapeutics Limited.
  • 15.10. EV Therapeutics

16. Strategic Recommendations

17. About Us & Disclaimer